Article
A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
20 Aug 2019
Abstract excerpt
BACKGROUND: This study aims to develop novel signatures for glioblastoma multiforme (GBM). METHODS: GBM expression profiles from The Cancer Genome Atlas (TCGA) were downloaded and DEGs between tumor and normal samples were identified by differential expression analysis (DEA). A risk signature was developed by applying weighted gene coexpression network analysis (WGCNA) and Cox regression analysis. Patients were...